Literature DB >> 27904170

Twenty-five-year-old Woman with Bilateral Borderline Ovarian Tumour Desiring to Preserve Fertility - Case Report and Literature Review on the Current State of Fertility Preservation in Women with Borderline Ovarian Tumours.

S Findeklee1, L Lotz1, K Heusinger1, I Hoffmann1, R Dittrich1, M W Beckmann1.   

Abstract

Borderline ovarian tumours are semimalignant tumours occurring unilaterally or bilaterally with a peak incidence among women of reproductive age. Since the affected women often wish to preserve fertility, particular precautions must be taken when counselling the patient and obtaining consent prior to planning an individual treatment. Options for preserving fertility include an organ-sparing surgical procedure and cryopreservation of oocytes and/or ovarian tissue. In this article, we report on a 25-year-old patient with a bilateral seromucinous borderline tumour who desired all fertility-preserving options. In order to perform the procedure without delay, we opted to perform luteal phase stimulation prior to oocyte retrieval. We conclude by discussing the current literature on the state of fertility preservation in the treatment of borderline ovarian tumours.

Entities:  

Keywords:  borderline tumour; fertility preservation; future wish for child; luteal phase stimulation; ovarian cryopreservation

Year:  2016        PMID: 27904170      PMCID: PMC5123880          DOI: 10.1055/s-0042-109267

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  28 in total

1.  Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study.

Authors:  G Zanetta; S Rota; S Chiari; C Bonazzi; G Bratina; C Mangioni
Journal:  J Clin Oncol       Date:  2001-05-15       Impact factor: 44.544

2.  Impact of infertility drugs after treatment of borderline ovarian tumors: results of a retrospective multicenter study.

Authors:  Anne Fortin; Philippe Morice; Anne Thoury; Sophie Camatte; Caroline Dhainaut; Patrick Madelenat
Journal:  Fertil Steril       Date:  2006-11-16       Impact factor: 7.329

3.  Treatment for fertility and risk of ovarian tumors of borderline malignancy.

Authors:  F Parazzini; E Negri; C La Vecchia; S Moroni; A Polatti; F Chiaffarino; M Surace; E Ricci
Journal:  Gynecol Oncol       Date:  1998-03       Impact factor: 5.482

4.  Different stimulation protocols for oocyte cryropreservation in oncological patients: a retrospective analysis of single university centre.

Authors:  Giovanna Simi; Maria Elena Rosa Obino; Elena Casarosa; Pietro Litta; Paolo Giovanni Artini; Vito Cela
Journal:  Gynecol Endocrinol       Date:  2015-09-15       Impact factor: 2.260

Review 5.  Clinical recommendation on fertility preservation in borderline ovarian neoplasm: ovarian stimulation and oocyte retrieval after conservative surgery.

Authors:  Dominik Denschlag; Michael von Wolff; Frederic Amant; Vesna Kesic; Nicholas Reed; Achim Schneider; Alexandros Rodolakis
Journal:  Gynecol Obstet Invest       Date:  2010-06-16       Impact factor: 2.031

6.  Reproductive risk factors for epithelial ovarian cancer according to histologic type and invasiveness.

Authors:  F Modugno; R B Ness; J E Wheeler
Journal:  Ann Epidemiol       Date:  2001-11       Impact factor: 3.797

7.  Feasibility of ovarian cryopreservation in borderline ovarian tumours.

Authors:  V Fain-Kahn; C Poirot; C Uzan; M Prades; S Gouy; C Genestie; P Duvillard; P Morice
Journal:  Hum Reprod       Date:  2008-12-19       Impact factor: 6.918

Review 8.  The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature.

Authors:  Mikkel Rosendahl; Tine Greve; Claus Yding Andersen
Journal:  J Assist Reprod Genet       Date:  2012-12-22       Impact factor: 3.412

Review 9.  Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.

Authors:  Michael von Wolff; Markus Montag; Ralf Dittrich; Dominik Denschlag; Frank Nawroth; Barbara Lawrenz
Journal:  Arch Gynecol Obstet       Date:  2011-03-24       Impact factor: 2.344

10.  Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.

Authors:  F Trillsch; S Mahner; E Vettorazzi; L Woelber; A Reuss; K Baumann; M-D Keyver-Paik; U Canzler; K Wollschlaeger; D Forner; J Pfisterer; W Schroeder; K Muenstedt; B Richter; C Fotopoulou; B Schmalfeldt; A Burges; N Ewald-Riegler; N de Gregorio; F Hilpert; T Fehm; W Meier; P Hillemanns; L Hanker; A Hasenburg; H-G Strauss; M Hellriegel; P Wimberger; S Kommoss; F Kommoss; S Hauptmann; A du Bois
Journal:  Br J Cancer       Date:  2015-01-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.